Skip to Content

Clinical Trials Details

Acorn MDV3100-11

Patient Information

Acorn MDV3100-11: A Phase 2, Single-Arm, Open-Label, Multicenter Study of the Clinical Activity and Safetyof Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple-Negative Breast Cancer

View more information about clinical trial - Acorn MDV3100-11

Study Number
Acorn MDV3100-11

Clinical Trial Categories

  • Breast Cancer - Metastatic


  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section